Renakart Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 16-11-2024
- Paid Up Capital ₹ 6.44 M
as on 16-11-2024
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 5.39%
(FY 2023)
- Profit 77.54%
(FY 2023)
- Ebitda 56.12%
(FY 2023)
- Net Worth 13.45%
(FY 2023)
- Total Assets 19.92%
(FY 2023)
About Renakart Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 6.44 M, as per Ministry of Corporate Affairs (MCA) records.
Sangita Vaingankar and Apeksha Harsha serve as directors at the Company.
- CIN/LLPIN
U24230KA2015PTC082430
- Company No.
082430
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Renakart Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Apeksha Harsha  | Director | 14-Aug-2017 | Current |
| Sangita Vaingankar | Director | 15-May-2017 | Current |
Financial Performance of Renakart Life Sciences.
Renakart Life Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.39% increase. The company also saw a substantial improvement in profitability, with a 77.54% increase in profit. The company's net worth Soared by an impressive increase of 13.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Renakart Life Sciences?
In 2023, Renakart Life Sciences had a promoter holding of 12.94% and a public holding of 87.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Torq 03 Sports & Adventures Private LimitedActive 16 years 5 monthsApeksha Harsha is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Renakart Life Sciences?
Unlock and access historical data on people associated with Renakart Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Renakart Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renakart Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
